T-5224, a selective c-Fos/activator protein-1 inhibitor, enhances survival by reducing serum HMGB1 levels in lethal lipopolysaccharide-induced AKI (Ishida et al., 2015). This evidence concerns the gene HMGB1 and acute kidney injury.